Literature DB >> 6207872

Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene cluster.

S H Boyer, G J Dover, G R Serjeant, K D Smith, S E Antonarakis, S H Embury, L Margolet, A N Noyes, M L Boyer, W B Bias.   

Abstract

Levels of fetal hemoglobin (HbF) bearing reticulocytes (F reticulocytes) range from 2% to 50% in patients with sickle cell (SS) anemia. To learn whether any portion of such variation in F cell production is regulated by loci genetically separable from the beta-globin gene cluster, percentages of F reticulocytes were compared in 59 sib pairs composed solely of SS members, including 40 pairs from Jamaica and 19 from the United States. We reasoned that differences in F reticulocyte levels might arise (1) from any of several kinds of artifact, (2) via half-sib status, or (3) because one or more genes regulating F cell production segregate separately from beta S. We minimized the role of artifact by assay of fresh samples from 84 SS individuals, including both members of 38 sib pairs. In 78 of the 84 subjects, serial values for percent F reticulocytes fell within 99.9% confidence limits or were alike by t test (P greater than or equal to .05). This left 32 sib pairs for which F reticulocyte levels in each member were reproducible. When sib-sib comparisons were limited to these 32 pairs, percentages of F reticulocytes were grossly dissimilar within 12 Jamaican and 3 American sibships. Within them, the probability that sibs were alike was always less than or equal to .005 and usually less than or equal to 10(-4). We next minimized the contribution of half-sibs among Jamaicans by a combination of paternity testing and sib-sib comparison of beta-globin region DNA restriction fragment length polymorphisms, especially among discordant pairs. We thereafter concluded that at least seven to eight Jamaican pairs were composed of reproducibly discordant full sibs. There is thus little doubt that there are genes regulating between-patient differences in F cell production that are separate from the beta-globin gene cluster. Still unanswered is (1) whether or not these genes are actually linked to beta S, (2) why F reticulocyte levels in Americans tend to be lower than in Jamaicans, and (3) whether or not differences in F cell production among SS patients are regulated by several major loci or by only one.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207872

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  The evolution of two west African populations.

Authors:  O C Stine; G J Dover; D Zhu; K D Smith
Journal:  J Mol Evol       Date:  1992-04       Impact factor: 2.395

2.  Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease.

Authors:  S R Month; R W Wood; P T Trifillis; P J Orchowski; B Sharon; S K Ballas; S Surrey; E Schwartz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Inhibition of erythroblast growth and fetal hemoglobin production by ribofuranose-substituted adenosine derivatives.

Authors:  Natarajan V Bhanu; Y Terry Lee; Patricia A Oneal; Nicole M Gantt; Wulin Aerbajinai; Pierre Noel; Craig J Thomas; Jeffery L Miller
Journal:  Biochim Biophys Acta       Date:  2008-06-30

4.  Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.

Authors:  Yan Dai; Jose Sangerman; Mehdi Nouraie; Aidan D Faller; Patricia Oneal; Angela Rock; Oluwakemi Owoyemi; Xiaomei Niu; Sergei Nekhai; Dashmeet Maharaj; Shauiying Cui; Robert Taylor; Martin Steinberg; Susan Perrine
Journal:  Am J Hematol       Date:  2016-11-18       Impact factor: 10.047

5.  Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.

Authors:  Betty S Pace; Susan Perrine; Biaoru Li; Levi Makala; Hongyan Xu; Mayuko Takezaki; Roman F Wolf; Amy Wang; Xin Xu; Junfeng Huang; Asaf Alimardanov; Gregory J Tawa; Jose Sangerman; Aidan Faller; Wei Zheng; London Toney; Sharie J Haugabook
Journal:  Blood Cells Mol Dis       Date:  2021-03-12       Impact factor: 2.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.